Detai Bioscience, Inc. (“DetaiBio”), established in 2013, is a CRO vendor focusing on antibody discovery and functional protein research field. DetaiBio is aiming to provide high quality and economic service to speed up life science for our client in different fields, such as antibody drug discovery, in-vitro diagnosis and academic research.

Currently, DetaiBio has established different platforms including FACS sorting, plasma cell sorting, hybridoma sequencing, single cell sequencing, structure analysis, high-throughput recombinant protein/recombinant antibody, stable cell line development etc, to support service upgrading, internal R&D and high QC standard.